Joseph A. Vetro, Ph.D. - Publications

2001 Saint Louis University, St. Louis, MO, United States 
Biochemistry, Molecular Biology

3/15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Vetro JA, Dummitt B, Micka WS, Chang YH. Evidence of a dominant negative mutant of yeast methionine aminopeptidase type 2 in Saccharomyces cerevisiae. Journal of Cellular Biochemistry. 94: 656-68. PMID 15547949 DOI: 10.1002/jcb.20285  0.76
2002 Vetro JA, Chang YH. Yeast methionine aminopeptidase type 1 is ribosome-associated and requires its N-terminal zinc finger domain for normal function in vivo. Journal of Cellular Biochemistry. 85: 678-88. PMID 11968008 DOI: 10.1002/jcb.10161  0.76
2002 Chen S, Vetro JA, Chang YH. The specificity in vivo of two distinct methionine aminopeptidases in Saccharomyces cerevisiae. Archives of Biochemistry and Biophysics. 398: 87-93. PMID 11811952 DOI: 10.1006/abbi.2001.2675  0.76
Low-probability matches
2015 Karuturi VK, Tallapaka SB, Phillips JA, Sanderson SD, Vetro JA. Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant. Clinical Immunology (Orlando, Fla.). PMID 26111481 DOI: 10.1016/j.clim.2015.06.006  0.08
2015 Wakaskar RR, Bathena SP, Tallapaka SB, Ambardekar VV, Gautam N, Thakare R, Simet SM, Curran SM, Singh RK, Dong Y, Vetro JA. Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after IV administration. Pharmaceutical Research. 32: 1028-44. PMID 25223962 DOI: 10.1007/s11095-014-1515-z  0.08
2011 Haney MJ, Zhao Y, Li S, Higginbotham SM, Booth SL, Han HY, Vetro JA, Mosley RL, Kabanov AV, Gendelman HE, Batrakova EV. Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells. Nanomedicine (London, England). 6: 1215-30. PMID 21449849 DOI: 10.2217/nnm.11.32  0.08
2011 Ambardekar VV, Han HY, Varney ML, Vinogradov SV, Singh RK, Vetro JA. The modification of siRNA with 3' cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes. Biomaterials. 32: 1404-11. PMID 21047680 DOI: 10.1016/j.biomaterials.2010.10.019  0.08
2009 Kakiuchi-Kiyota S, Vetro JA, Suzuki S, Varney ML, Han HY, Nascimento M, Pennington KL, Arnold LL, Singh RK, Cohen SM. Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouse. Toxicology and Applied Pharmacology. 237: 83-90. PMID 19285096 DOI: 10.1016/j.taap.2009.02.028  0.08
2005 Braun CS, Vetro JA, Tomalia DA, Koe GS, Koe JG, Middaugh CR. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. Journal of Pharmaceutical Sciences. 94: 423-36. PMID 15614818 DOI: 10.1002/jps.20251  0.08
2003 Lobo BA, Vetro JA, Suich DM, Zuckermann RN, Middaugh CR. Structure/function analysis of peptoid/lipitoid:DNA complexes. Journal of Pharmaceutical Sciences. 92: 1905-18. PMID 12950008 DOI: 10.1002/jps.10450  0.08
2020 Alshammari A, Smith DD, Parriott J, Stewart JP, Curran SM, McCulloh RJ, Barry PA, Iyer SS, Palermo N, Phillips JA, Dong Y, Ronning DR, Vennerstrom JL, Sanderson SD, Vetro JA. Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67. Acs Infectious Diseases. PMID 32233506 DOI: 10.1021/acsinfecdis.0c00005  0.04
2019 Tallapaka SB, Karuturi BVK, Yeapuri P, Curran SM, Sonawane YA, Phillips JA, David Smith D, Sanderson SD, Vetro JA. Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection. International Journal of Pharmaceutics. 565: 242-257. PMID 31077762 DOI: 10.1016/j.ijpharm.2019.05.012  0.01
2018 Ambardekar VV, Wakaskar RR, Ye Z, Curran SM, McGuire TR, Coulter DW, Singh RK, Vetro JA. Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration. International Journal of Pharmaceutics. PMID 29601972 DOI: 10.1016/j.ijpharm.2018.03.045  0.01
2017 Karuturi BV, Tallapaka SB, Yeapuri P, Curran SM, Sanderson SD, Vetro JA. Encapsulation of an EP67-conjugated CTL peptide vaccine in nanoscale biodegradable particles increases the efficacy of respiratory immunization and affects the magnitude and memory subsets of vaccine-generated mucosal and systemic CD8+ T cells in a diameter-dependent manner. Molecular Pharmaceutics. PMID 28319404 DOI: 10.1021/acs.molpharmaceut.6b01088  0.01
2013 Ambardekar VV, Wakaskar RR, Sharma B, Bowman J, Vayaboury W, Singh RK, Vetro JA. The efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG(5K). Biomaterials. 34: 4839-48. PMID 23557861 DOI: 10.1016/j.biomaterials.2013.03.021  0.01
Hide low-probability matches.